Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
67 Cards in this Set
- Front
- Back
how does asprin cause asthma |
because it blocks cyclooxgenase pathway leading to arachidonic acid diverted to leukotrienes which leads to build up and severe bronchoconstriction |
|
two types of anti-asthma drugs |
drugs that prevent bronchconstriction drugs that cause bronchodilation |
|
two types of bronchodilators |
B2 agonists Theophylline |
|
4 types of anti-asthma drugs that passively prevent bronchoconstriction |
1. Ipratropium 2. Theophylline 3. Lukast 4. Zileuton |
|
which anti-leukotriene blocks enzyme phospholipase A2 |
glucocorticoids |
|
which anti-leukotriene blocks enzyme lipoxygenase |
zileuton |
|
if leukotrienes are produced anyway what is used and why |
zafirlukast or montelukast because it blocks interaction of leukotrienes with leukotriene receptors |
|
4 types of bronchodilation therapy drugs |
1. B-2 agonists 2. Muscarinic antagonists 3. Adenosine and cAMP phosphodiesterase 4. Leukotriene antagonists |
|
how do beta 2 agonist work |
they are G-s receptors that increase cAMP and cause bronchodilation |
|
two types of beta-agonists |
short acting and long acting |
|
3 types of short acting B2 agonists |
1. albuterol 2. Terbutaline 3. Levalbuterol |
|
2 types of long acting B2 agonists |
1. Salmeterol 2. Formoterol |
|
how do beta 2 agonists act as bronchdilators |
they phosphorylate MLCK which is an inactive form. if inactivated there is none available for activating MLC so there is no contraction. |
|
FDA warning for long lasting beta 2 agonists |
they increase the death rate from asthma attacks, especially in blacks |
|
even if a patient is on a long lasting beta 2 agonist what should be given if they show signs on an acute attack |
rapid acting beta 2 agonist such as albuterol inhaler should be used |
|
side effects of beta 2 agonist |
tremors and cardiovascular toxicity |
|
chronic use of beta 2 agonist leads to what |
downregulation (tolerance) |
|
what is given with status asthmaticus |
4 puffs of albuterol every 20 minutes for one hour |
|
if attack lasts longer than one hour |
patient needs to go to the hospital. on the way, a corticosteroid may be administered |
|
two types of anti-cholinergic drugs |
atropine ipratropium bromide |
|
mechanism of action for anti-cholinergic drugs |
they block M3 receptors on smooth muscle |
|
when are these drugs useful |
only when vagal tone is a contributing factor |
|
three types of methylxanthines |
caffeine theophylline aminophylline (given as IV infusion) |
|
major mechanism of action for methylxanthines |
competitive antagonist at adenosine receptors |
|
other two mechanisms |
inhibits phosphodiesterase leading to an increase in cAMP prevents calcium mediated contractions |
|
which methylxanthines is used to treat status asmathicus |
aminophylline |
|
adverse effects of theophylline are dependent on what |
dose |
|
high doses of theophylline can lead to what |
convulsions and tachycardia |
|
theophylline has what size therapeutic range |
small |
|
4 types of anti-inflammatory agents |
1. glucocorticoids 2. mast cell stabilizers 3. leukotriene synthesis inhibitors/antagonists 4. anti IgE antibody |
|
4 types of corticosteroids used in asthma |
1. Beclomethasone 2. Budesonine 3. Fluticasone 4. Triamcinolone |
|
main side effect of inhaled corticosteroid use |
oral candidiasis |
|
why? |
deposition of corticosteroids in oral mucosa. over a long period leads to local immunosuppression |
|
two other side effects from long term use of inhaled corticosteroid |
1. Osteoporosis 2. Cataracts |
|
two types of mast cell stabilizers |
cromolyn sodium nedocromil |
|
do mast cell stabilizers bronchodilate |
no, they prevent the release of inflammatory mediators such as histamine |
|
most popular leukotriene inhibitor |
montelukast |
|
side effects of leukotriene inhibitors |
Inhibits chemotaxis leading to severe bacterial infection Liver toxicity in the use of Zileuton |
|
type of humanized monoclonal anti-IgE antibody used in the treatment of severe allergic asthma |
omalizumab |
|
how does it work |
it neutralizes IgE by binding to serum IgE which prevents interaction with IgE receptors |
|
when is it used and why |
it is only used in resistant conditions because it is very expensive |
|
when is epinephrine used |
in status asthmaticus |
|
when severe, what can status asthmaticus cause |
respiratory acidosis |
|
how do expectorants work |
they increase tracheobronchial secretions or breaks the disulfide bond in vicid mucus |
|
two popular expectorants |
ammonium salts acetyl cysteine |
|
main difference between asthma and COPD |
no reversible constriction in COPD |
|
what drug improves COPD |
long lasting tiotropium |
|
seasonal rhinitis is also known as what |
hayfever |
|
which type occurs throughout the year |
perennial allergic rhinitis |
|
antihistamnes act on what type of receptors |
H1 |
|
what is the mechanism of action |
they are H1 receptor antagonists |
|
antihistamines have what type of properties |
anticholinergic (1st generation agents) |
|
one of the major problems with antihistamines |
sedation |
|
4 types of nonselective first generation oral antihistamines |
1. Brompheniramine 2. Chlorpheniramine 3. Clemastine 4. Diphenhydramine |
|
peripherally selective 2nd generation oral antihistamines |
1. Cetirizine 2. Levocetririzine 3. Fexofendadine 4. Loratadine 5. Desloratadine |
|
CNS depression is least likely to occur with which second generation oral antihistamine |
Fexofenadine |
|
what intranasal antihistamine is used for relieving allergic rhinorrhea |
Azelastine |
|
oral decongestants |
phenylephrine pseudoephedrine |
|
two most important intranasal decongestants |
phenylephrine oxymetazoline |
|
biggest problem with intranasal decongestants |
rhinitis medicamentosa |
|
what happens |
with prolonged used, over 3-5 days, congestion will come back due to downregulation |
|
drug of choice for allergic rhinitis |
intranasal corticosteroids |
|
3 types of intranasal corticosteroids |
1. Flunisolide 2. Fluticasone 3. Mometasone |
|
mechanism of action for intranasal cromolyn |
mast cell stabilizer- prevents inflammatory mediator release |
|
mechanism of action for intranasal anticholinergic |
it blocks the action of acetylcholine |
|
mechanism of action for montelukast |
leukotriene receptor antagonist |
|
does montelukast treat an attack |
no |